Particle.news
Download on the App Store

Breakthrough Prizes Honor Muon Precision and Gene‑Therapy Milestones

The $3 million awards spotlight patient-ready gene therapies alongside precision physics with open theoretical questions.

Overview

  • The Breakthrough Prize organizers announced the 2026 winners on April 18, awarding $3 million to laureates across fundamental physics, life sciences, and mathematics.
  • The muon team measured the particle’s magnetic g‑factor with 127‑parts‑per‑billion precision, results viewed as consistent with the Standard Model even as two leading theory calculations still conflict.
  • The muon award will be shared by several hundred collaborators from CERN, Brookhaven, and Fermilab, recognizing decades of work tracking the muon’s tiny wobble in magnetic fields.
  • Life‑sciences honors included Luxturna’s developers for a gene‑augmenting therapy that restores navigation in low light for people with RPE65‑related blindness, and researchers who mapped BCL11A’s role in hemoglobin switching to enable Casgevy, the first FDA‑approved gene‑editing treatment for sickle‑cell disease and β‑thalassaemia.
  • Other top awards went to Frank Merle for breakthroughs on non‑linear equations that yield stable wave solutions called solitons, and to David Gross for advances on the strong force and string theory and for championing global scientific collaboration.